Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy
β Scribed by Linda J. Adepoju; W. Fraser Symmans; Gildy V. Babiera; S. Eva Singletary; Banu Arun; Nour Sneige; Lajos Pusztai; Thomas A. Buchholz; Aysegul Sahin; Kelly K. Hunt; Funda Meric-Bernstam; Merrick I. Ross; Frederick C. Ames; Henry M. Kuerer
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 101 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The authors reviewed their institution's experience treating patients with mammographically detected ductal carcinoma in situ (DCIS) of the breast with breast-conserving therapy (BCT) to determine 10-year rates of local control and survival and to identify factors associated with local recurrence.
## Abstract ## BACKGROUND The purpose of the current analysis was to evaluate the impact of local recurrence (LR) on the development of distant metastases (DM), overall survival (OS), and cause specific survival (CSS) in patients with earlyβstage breast carcinoma who underwent conservative surgery